Funded Tech Companies
LigoCyte Pharmaceuticals
Headquartered in Bozeman, LigoCyte Pharmaceuticals was acquired by Takeda Pharmaceuticals.
Company Overview
Company Name
LigoCyte Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2155 Analysis Drive
Bozeman, MT 59718
USA
Bozeman, MT 59718
USA
Phone
Website
Email Address
Company Background Information
Overview
LigoCyte is breaking new ground in the treatment of inflammatory and infectious disease. We have produced a number of novel drug compounds to modify immune responses by focusing on cell binding interactions and their role in the immune system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/8/2012
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Beeman
Chief Medical Officer
Paul Mendelman
Chief Scientific Officer
Robert Bargatze
Controller
Larry Mikkola
President
Robert Goodwin
VP - R & D
Charles Richardson
Company Investors
- Novartis Venture Fund (Markus Goebel)
- F-Prime Capital (Benjamin Auspitz)
- MedImmune Ventures
- Novartis BioVenture Fund
- Athenian Venture Partners
- Rally Ventures
- Forward Ventures (Ivor Royston)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs